Japan· JP-3999040F1026
イバンドロン酸ナトリウム水和物
A ibandronic acid product containing イバンドロン酸ナトリウム水和物, registered in Japan by 大正製薬, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Ibandronic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC M05BA06 (ibandronic acid), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 10 of them publish a price we can compare per daily dose
Ibandronic acid · ATC M05BA06
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ibandronic acid costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.089 in United States to $1.30 in Switzerland — a ×15 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ibandronic acid · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.30
- ES Spain$0.49
- IT Italy$0.38
- US United States$0.089 (acquisition cost)
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- イバンドロン酸ナトリウム水和物
- Manufacturer
- 大正製薬
- Country
- Japan (JP)
- ATC code
- M05BA06
- ATC class
- Ibandronic acid
- Defined daily dose
- 5 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
228 interactions on record for ibandronic acid.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibandronic acid · interactions on record
228 records
- 12 severe
- 98 moderate
- 94 info
Most severe, free to view
- EtelcalcetideH05BX04severe
- SirolimusL01EG04severe
- SirolimusL04AA10severe
- TacrolimusL04AD02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M05BA06
Ibandronic acid, as other registers publish it.
- ItalyACIDO IBANDRONICO ALTERLABORATORI ALTER S.R.L.
- SpainACIDO IBANDRONICO APOTEX 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGApotex Europe B.V.
- ItalyACIDO IBANDRONICO AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- SpainACIDO IBANDRONICO AUROBINDO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Aurobindo S.L.U.
- ItalyACIDO IBANDRONICO DOC GENERICIDOC GENERICI S.R.L.
- ItalyACIDO IBANDRONICO EGEG S.P.A.
- ItalyACIDO IBANDRONICO MYLANMYLAN S.P.A.
- ItalyACIDO IBANDRONICO PENSATOWA PHARMACEUTICAL S.P.A.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/debfb9c6-9695-4900-b4d8-078279cdc1c1 GET /v1/drugs/debfb9c6-9695-4900-b4d8-078279cdc1c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999040F1026",
"category": "内用薬",
"price_yen": 1360.9,
"generic_name": "イバンドロン酸ナトリウム水和物",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about ibandronic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.